1Ornellas AA,Seixas ALC,Marota A,et al.Surgical treatment of invasive squamous cell carcinoma of penis: retrospective analysis of 350 cases.J Urol,1994,151:1244-1249.
2Solsora E,Iborra I,Rubio J,et al.Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes.J Urol,2001,165:1506-1509.
2Protzel C, Alcaraz A, Horenblas S, et al. Lymphadenectomy in the surgical management of penile cancer. Eur Urol, 2009, 55 : 1075-1088.
3Gotsadze D, Matveev B, Zak B, et al. Is conservative organsparing treatment of penile carcinoma justified? Eur Urol, 2000, 38 : 306-312.
4Soria JC, Fizazi K, Piron D, et al. Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in a monocentric study with a conservative policy. Ann Oncol, 1997, 8: 1089-1098.
5Spratt J. Groin dissection. J Surg Oneol, 2000, 73: 243-262.
6Loughlin KR. Surgical management of penile carcinoma: the inguinal nodes. BJU Int, 2006, 97: 1125-1134.
7Sobin LH, Wittekind Ch. TNM classification of malignant tumours 6th ed. New York: Wiley & Sons, 2002: 303-308.
8Lopes A, Bezerra A, Pinto C, et al. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol, 2002, 168: 81-86.
9Graafland NM, Moonen LM, van Boven HH, et al. Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management. J Urol, 2011, 185: 888-893.
10Protzel C, Hakenberg OW. Chemotherapy in patients with penile carcinoma. Urol Int, 2009, 82: 1-7.
